TRAX
First Tracks Biotherapeutics
NASDAQ: TRAX · HEALTHCARE · BIOTECHNOLOGY
$23.27
-1.57% today
Updated 2026-04-30
Market cap
$821.46M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-4.71
Dividend yield
—
52W range
$11 – $27
Volume
0.7M
First Tracks Biotherapeutics (TRAX) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item |
|---|
| Operating cash flow |
| Capital expenditures |
| Depreciation |
| Stock-based comp |
| Free cash flow |
| Investing cash flow |
| Financing cash flow |
| Dividends paid |
| Share repurchases |
| Debt repayment |
| Net change in cash |